Matthieu Coutet

Image

Matthieu brings 12 years of experience in venture capital and operations, having spent a decade in tech transfer as Managing Partner at Inserm Transfert Initiative. He handled investments in 14 seed-stage companies. He also served as VP Operations & Business Development at TherAchon and AAVlife, 2 French biotechnology start-ups, and as a board member of 7 others (Axilum Robotics, BioAxial, Aelis Farma, Enyo Pharma, Hemarina, Sensorion and Eyevensys). Matthieu founded Advent France Biotechnology with Alain Huriez in 2016. Matthieu not only brings an experience of early stage investor managing financial and operational strategies, but also a strong network of researchers, entrepreneurs and technology transfer officers with whom he has forged significant partnerships. Matthieu holds a Masters in Finance & Management and an MSc from ESIEE (Paris).